Heart failure drug study halted early – only 4 patients enrolled
Symptom relief
Terminated
This early-stage study tested a new drug called HS135 in obese patients who have both heart failure with preserved pumping ability and high blood pressure in the lungs. The goal was to check the drug's safety and how the body processes it. Only 4 people took part before the study…
Phase: PHASE1 • Sponsor: 35Pharma Inc • Aim: Symptom relief
Last updated May 01, 2026 16:00 UTC